Shuichi Ikeyama

1.0k total citations
13 papers, 901 citations indexed

About

Shuichi Ikeyama is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Shuichi Ikeyama has authored 13 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Immunology. Recurrent topics in Shuichi Ikeyama's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Chemical Synthesis and Analysis (3 papers). Shuichi Ikeyama is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Chemical Synthesis and Analysis (3 papers). Shuichi Ikeyama collaborates with scholars based in Japan. Shuichi Ikeyama's co-authors include Masaru Koyama, Masayuki Miyake, Mitsuaki Yamaoka, Tadashi Yamamoto, Reiko Sasada, Masaharu Seno, Takashi Fujita, Kenichi Sudo, Takeshi Fujita and K. Sudo and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Biochemical and Biophysical Research Communications.

In The Last Decade

Shuichi Ikeyama

13 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuichi Ikeyama Japan 10 546 307 270 191 146 13 901
IR Hart United Kingdom 14 594 1.1× 151 0.5× 317 1.2× 168 0.9× 134 0.9× 18 976
C H Blood United States 9 481 0.9× 204 0.7× 221 0.8× 318 1.7× 61 0.4× 10 883
Karen Kaye Smith United States 6 706 1.3× 246 0.8× 110 0.4× 150 0.8× 108 0.7× 8 964
Gaynor Davies United Kingdom 19 576 1.1× 141 0.5× 351 1.3× 255 1.3× 87 0.6× 22 1.0k
Doreen LePage United States 11 450 0.8× 101 0.3× 291 1.1× 85 0.4× 163 1.1× 24 888
Vinay Bhaskar United States 9 458 0.8× 169 0.6× 211 0.8× 119 0.6× 135 0.9× 14 816
R Yabkowitz United States 10 574 1.1× 168 0.5× 152 0.6× 352 1.8× 246 1.7× 12 880
Kym L. Stanley Australia 9 588 1.1× 134 0.4× 310 1.1× 123 0.6× 107 0.7× 10 893
M. Mareel Belgium 11 894 1.6× 238 0.8× 363 1.3× 151 0.8× 68 0.5× 24 1.3k
Danielle K. Lynch Australia 8 815 1.5× 253 0.8× 388 1.4× 143 0.7× 149 1.0× 8 1.2k

Countries citing papers authored by Shuichi Ikeyama

Since Specialization
Citations

This map shows the geographic impact of Shuichi Ikeyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichi Ikeyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichi Ikeyama more than expected).

Fields of papers citing papers by Shuichi Ikeyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuichi Ikeyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichi Ikeyama. The network helps show where Shuichi Ikeyama may publish in the future.

Co-authorship network of co-authors of Shuichi Ikeyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shuichi Ikeyama. A scholar is included among the top collaborators of Shuichi Ikeyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuichi Ikeyama. Shuichi Ikeyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hori, Ai, Shuichi Ikeyama, & K Sudo. (1994). Suppression of Cyclin D1 mRNA Expression by the Angiogenesis Inhibitor TNP-470 (AGM-1470) in Vascular Endothelial Cells. Biochemical and Biophysical Research Communications. 204(3). 1067–1073. 60 indexed citations
2.
Ikeyama, Shuichi, et al.. (1993). Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.. The Journal of Experimental Medicine. 177(5). 1231–1237. 255 indexed citations
3.
Yamaoka, Mitsuaki, Tadashi Yamamoto, Shuichi Ikeyama, Kenichi Sudo, & Takashi Fujita. (1993). Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.. PubMed. 53(21). 5233–6. 140 indexed citations
4.
Yamaoka, Mitsuaki, et al.. (1993). Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).. PubMed. 53(18). 4262–7. 147 indexed citations
5.
Harada, Kaori, et al.. (1992). Therapeutic Effect of Ansamitocin Targeted to Tumor by a Bispecific Monoclonal Antibody. Japanese Journal of Cancer Research. 83(7). 761–768. 12 indexed citations
6.
Miyake, Masayuki, Masaru Koyama, Masaharu Seno, & Shuichi Ikeyama. (1991). Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.. The Journal of Experimental Medicine. 174(6). 1347–1354. 170 indexed citations
7.
Honda, Susumu, Tsuneo Asano, Shizue Nakagawa, et al.. (1987). Differential Purification by Immunoaffinity Chromatography of Two Carboxy-Terminal Portion-Deleted Derivatives of Recombinant Human Interferon-γ from Escherichia coli. Journal of Interferon Research. 7(2). 145–154. 23 indexed citations
8.
Ichimori, Yuzo, Tsutomu Kurokawa, Shuichi Ikeyama, Reiko Sasada, & K. Tsukamoto. (1985). Establishment of Hybridomas Secreting Monoclonal Antibodies Against Cε2 and Cε4 Domains of Human IgE. Hybridoma. 4(1). 47–53. 7 indexed citations
9.
Ikeyama, Shuichi, et al.. (1984). Radioimmunoassay of Serum Thymic Factor (FTS). Journal of Immunoassay. 5(1-2). 87–97. 6 indexed citations
10.
Ikeyama, Shuichi & Masao Takeuchi. (1981). Antitubulin activities of ansamitocins and maytansinoids. Biochemical Pharmacology. 30(17). 2421–2425. 9 indexed citations
11.
Kato, Koichi, Shuichi Ikeyama, Muneo Takaoki, et al.. (1981). Epithelial cell components immunoreact with antiserum thymic factor (FTS) antibodies: Possible association with intermediate-sized filaments. Cell. 24(3). 885–895. 32 indexed citations
12.
Ootsu, Koichiro, Yoshio Kozai, Masao Takeuchi, et al.. (1980). Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine tumors in vivo and on the assembly of microtubules in vitro.. PubMed. 40(5). 1707–17. 22 indexed citations
13.
Igarashi, Koichi, Shuichi Ikeyama, Masao Takeuchi, & Yukio Sugino. (1978). Morphological Changes in Rat Glioma Cells caused by Adenosine Cyclic 3', 5'-Monophosphate. Cell Structure and Function. 3(2). 103–112. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026